Fatty liver, also known as hepatic steatosis, is a buildup of fat in the liver. It’s normal to have some fat in your liver, but more than 5% of your liver weight as fat is considered fatty liver. Having too much fat in your liver is concerning because it can lead to serious health problems like cirrhosis, liver failure, and liver cancer.
Fatty liver is usually diagnosed through imaging tests like an abdominal ultrasound, CT scan, or MRI scan. These scans allow doctors to see fat in the liver. However, blood tests are also important in evaluating and monitoring fatty liver. While blood tests can’t definitively diagnose fatty liver on their own, they can provide clues and additional information to help detect and manage the condition.
Can Blood Tests Detect Fatty Liver?
Blood tests alone cannot conclusively diagnose fatty liver. An imaging test is needed to visually confirm the presence of fat in the liver. However, certain blood tests may raise suspicion for fatty liver.
Some of the most common blood tests that may indicate fatty liver include:
– Liver enzymes – Elevated levels of liver enzymes like ALT, AST, GGT, and ALP can signal liver injury and inflammation that may be caused by fatty liver. However, many conditions can raise liver enzymes, so enzymes alone don’t specifically indicate fatty liver.
– Fasting glucose and HbA1c – High blood sugar and diabetes are associated with an increased risk of fatty liver. Elevated fasting blood glucose and HbA1c levels may raise suspicion for fatty liver.
– Lipid panel – Abnormal cholesterol and triglyceride levels are associated with fatty liver. High triglycerides specifically can indicate excess fat accumulation in the liver.
– Albumin – Low blood albumin levels can occur when the liver is damaged and unable to produce this protein effectively.
– Bilirubin – Increased bilirubin may indicate impaired liver function and cholestasis that can be seen with fatty liver.
While these blood test results may raise suspicion for potential fatty liver, they can’t definitively diagnose the condition. Fatty liver often needs to be confirmed by imaging. However, these blood tests are still useful for identifying associated conditions like metabolic syndrome and monitoring for indications of liver injury.
What Blood Tests Help Monitor Fatty Liver?
Once fatty liver is diagnosed, regular blood tests are important to monitor liver health and guide treatment. Some key blood tests include:
– Liver enzymes – Tracking enzymes like ALT, AST, ALP, and GGT over time provides an indication of whether liver inflammation is stable, improving, or worsening.
– Fasting glucose and HbA1c – Monitoring glucose and diabetes control is important, as improving glycemic control can help treat associated fatty liver.
– Lipid panel – Assessing triglyceride, cholesterol, and LDL levels is useful for monitoring metabolic health.
– Albumin and bilirubin – Worsening levels may signal advancing liver damage.
– Complete blood count (CBC) – CBC helps identify complications like anemia.
– INR – Elevated INR can indicate impaired liver function and need for caution with medications.
– Vitamin levels – Fatty liver patients may need vitamin A, B12, D and E monitoring. Deficiencies may occur.
– Liver kidney microsomal type 1 antibody (LKM1) – May help distinguish NASH from other forms of fatty liver.
Tracking these blood tests over time, along with follow up imaging, allows evaluation of fatty liver treatment effectiveness and progression. Sudden worsening of blood tests warrants prompt medical attention.
What are Normal Liver Enzyme Levels in Blood Tests?
Checking liver enzyme levels is one of the most useful ways blood tests can assist with diagnosing and monitoring fatty liver. But what levels are considered normal?
Here are typical normal reference ranges for common liver enzymes:
– ALT – Alanine aminotransferase. Normal range 7-55 units/liter
– AST – Aspartate aminotransferase. Normal range 10-40 units/liter
– ALP – Alkaline phosphatase. Normal range 30-120 units/liter
– GGT – Gamma-glutamyl transferase. Normal range 5-55 units/liter
– Total Bilirubin – Normal range 0.1-1.2 mg/dl
– Direct Bilirubin – Normal range 0-0.3 mg/dl
– Albumin – Normal range 3.5-5 g/dl
Any elevation above the normal range may indicate possible liver injury. In fatty liver, ALT and AST are most likely to be elevated. Mild elevations under 100 U/L are common in fatty liver. Severe elevations over 400 U/L warrant quick medical assessment. Trends are also important, with rapidly increasing or decreasing enzymes needing evaluation.
What Other Blood Tests are Used for Fatty Liver Screening?
Beyond liver enzymes, fatty liver screening and diagnosis may include:
– **Complete metabolic panel** – Assesses kidney function, electrolytes, blood sugar, and fluid balance. Helps identify metabolic abnormalities associated with fatty liver.
– **Lipid panel** – Measures cholesterol, triglycerides, and lipid profiles. Directly assesses metabolic factors linked to fatty liver.
– **Glycohemoglobin (A1c)** – Provides glucose control monitoring. Fatty liver has a strong association with elevated blood glucose and diabetes.
– **CBC** – Checks for anemia and immune abnormalities that can accompany liver disease.
– **Iron studies** – Elevated ferritin levels can help identify hemochromatosis, an iron overload disorder that raises fatty liver risk.
– **Hepatitis viral serologies** – Helps rule out viral hepatitis which can also cause liver injury.
– **Celiac screening** – Celiac disease is associated with an increased occurrence of fatty liver. Tissue transglutaminase antibodies may be checked.
– **Thyroid studies** – Fatty liver is more common in hypothyroidism. Thyroid levels provide useful clinical information.
– **Protein electrophoresis** – Helps identify chronic liver diseases and screen for conditions like hepatitis C.
Careful selection of blood tests, in conjunction with imaging, provides the most complete fatty liver evaluation. Ongoing blood testing also assists in monitoring of treatment response.
How Often Should Blood Tests be Done for Fatty Liver?
There are no definitive medical guidelines for how often blood tests should be performed for fatty liver patients. Testing frequency is tailored to the individual based on symptoms, exam findings, degree of liver injury, and response to treatment.
Some general recommendations based on expert input for blood test monitoring include:
– At diagnosis – Baseline blood tests are advised when fatty liver is first identified. Establishes a starting point for enzyme levels, glycemic control, and other measures.
– Every 6 months – For mild stable fatty liver, blood tests every 6 months helps monitor trends.
– Every 3 months – When elevated enzymes or diabetes are present, testing every 3 months enables closer observation.
– Monthly – With advanced fatty liver causing substantial liver damage, monthly blood work may be warranted to catch deteriorating function.
– With medication changes – Check levels about 6 weeks after starting new fatty liver medications. Assess response.
– With symptoms – If new possible liver-related symptoms develop like jaundice or ascites, prompt blood testing is required.
Talk with your doctor about the right fatty liver blood testing schedule for you based on your individual health status and risks. Be sure to follow up regularly as recommended.
Fatty Liver Blood Test Results Interpretation
Interpreting fatty liver blood test results requires a clinician to look at the full picture of all results, medical history, and additional clinical information. However, some key findings provide insight:
– **Elevated liver enzymes** – ALT and AST over 100 U/L typically indicates substantial fatty liver inflammation and liver cell injury. Degree of elevation correlates with severity.
– **High ALP and GGT** – Can indicate bile duct damage from advanced fatty liver leading to cholestasis.
– **Low albumin** – Levels below 3 g/dl signal significant liver impairment and reduced production of proteins like albumin.
– **High triglycerides** – Triglyceride levels over 200 mg/dl are associated with greater fatty liver severity, especially when coupled with high ALT/AST.
– **High blood glucose** – Hemoglobin A1c over 6.5% suggests poor blood sugar control that can promote fatty liver progression.
– **Low platelet count** – Thrombocytopenia under 150,000 may result from portal hypertension and spleen enlargement from advanced fatty liver.
– **High bilirubin** – Marked direct bilirubin elevation over 3.0 mg/dl indicates cholestasis and advanced liver disease.
Of course, always discuss your particular blood test results with your hepatologist. Ongoing periodic testing provides the full scope for assessing disease state and response to therapy.
Limitations of Using Blood Tests for Fatty Liver
While blood tests offer useful information, there are some limitations when using them to evaluate fatty liver:
– **Cannot definitively diagnose** – Blood tests alone without imaging cannot confirm a diagnosis of fatty liver. Results can only raise suspicion.
– **Normal enzymes possible** – Some people with fatty liver have normal liver enzyme levels. Lack of enzyme elevation doesn’t rule out fatty liver.
– **Enzymes may fluctuate** – Transient enzyme elevations doesn’t always reflect permanent damage. Levels can go up and down.
– **Non-specific** – Many conditions beyond fatty liver can cause abnormal test results. Results must be interpreted in full clinical context.
– **Not precise** – Blood tests give limited details on how much fat is present or precisely what degree of inflammation exists. Imaging gives direct visual data.
– **Delayed changes** – Blood test changes lag behind actual tissue damage. May take weeks for enzyme elevations to manifest after an insult.
– **Sampling error** – Single samples may miss temporary abnormalities. Multiple results over time provide more complete data.
While very useful, blood tests for assessing fatty liver should always be combined with imaging tests and full clinical correlation for proper diagnosis and management.
Takeaways on Fatty Liver Blood Testing
In summary, key takeaways to remember about using blood tests to evaluate fatty liver include:
– Blood tests alone cannot definitively diagnose fatty liver but they can provide supporting information to raise suspicion. Imaging confirmation is needed.
– Liver enzymes like ALT, AST, GGT, and ALP may be elevated due to fatty liver but can also be elevated by many other conditions.
– Fatty liver blood tests are very helpful for monitoring disease progression and treatment response when combined with imaging.
– No single “diagnostic panel” exists but combinations of metabolic, liver, kidney, cholesterol, and glucose testing offer the most insight.
– Testing frequency varies based on severity, from every 6 months for stable mild disease to monthly for advanced fatty liver.
– Work closely with your hepatologist to understand your blood test results and what frequency of testing is needed in your situation.
While imperfect, blood testing remains a vital part of properly diagnosing and managing fatty liver disease. When combined with imaging and clinical correlation, fatty liver blood tests provide an important piece of the puzzle in caring for this condition.
References
1. Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2018). The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology (Baltimore, Md.), 67(1), 328–357.
2. Hazlehurst, J. M., Woods, C., Marjot, T., Cobbold, J. F., & Tomlinson, J. W. (2016). Non-alcoholic fatty liver disease and diabetes. Metabolism: clinical and experimental, 65(8), 1096–1108.
3. Wong, V. W., Wong, G. L., Choi, P. C., Chan, A. W., Li, M. K., Chan, H. Y., Chim, A. M., Yu, J., Sung, J. J., & Chan, H. L. (2010). Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut, 59(7), 969–974.
4. Kwok, R., Choi, K. C., Wong, G. L., Zhang, Y., Chan, H. L., Luk, A. O., Shu, S. S., Chan, A. W., Yeung, M. W., Chan, J. C., & Wong, V. W. (2016). Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study. Gut, 65(8), 1359–1368.
5. Vuppalanchi, R., Gould, R. J., Wilson, L. A., Unalp-Arida, A., Cummings, O. W., Chalasani, N., & Kowdley, K. V. (2011). Clinical significance of a rise in alanine aminotransferase levels during methotrexate therapy for non-alcoholic fatty liver disease. Alimentary pharmacology & therapeutics, 34(2), 287–295.
